Annual CAPEX
$936.20 K
-$5.52 M-85.50%
31 December 2023
Summary:
Cytosorbents annual capital expenditures is currently $936.20 thousand, with the most recent change of -$5.52 million (-85.50%) on 31 December 2023. During the last 3 years, it has fallen by -$740.00 thousand (-44.15%). CTSO annual CAPEX is now -85.50% below its all-time high of $6.46 million, reached on 31 December 2022.CTSO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$298.40 K
+$178.50 K+148.87%
30 September 2024
Summary:
Cytosorbents quarterly capital expenditures is currently $298.40 thousand, with the most recent change of +$178.50 thousand (+148.87%) on 30 September 2024. Over the past year, it has increased by +$40.70 thousand (+15.79%). CTSO quarterly CAPEX is now -93.63% below its all-time high of $4.68 million, reached on 30 June 2022.CTSO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$681.20 K
+$40.70 K+6.35%
30 September 2024
Summary:
Cytosorbents TTM capital expenditures is currently $681.20 thousand, with the most recent change of +$40.70 thousand (+6.35%) on 30 September 2024. Over the past year, it has dropped by -$325.20 thousand (-32.31%). CTSO TTM CAPEX is now -91.72% below its all-time high of $8.22 million, reached on 30 June 2022.CTSO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -85.5% | +15.8% | -32.3% |
| 3 y3 years | -44.1% | -70.7% | -76.3% |
| 5 y5 years | -38.4% | -5.4% | -52.7% |
CTSO CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -85.5% | at low | -93.6% | +312.7% | -91.7% | +79.1% |
| 5 y | 5 years | -85.5% | at low | -93.6% | +312.7% | -91.7% | +79.1% |
| alltime | all time | -85.5% | +2312.9% | -93.6% | +312.7% | -91.7% | >+9999.0% |
Cytosorbents CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $298.40 K(+148.9%) | $681.20 K(+6.4%) |
| June 2024 | - | $119.90 K(-5.6%) | $640.50 K(+68.4%) |
| Mar 2024 | - | $127.00 K(-6.5%) | $380.30 K(-59.4%) |
| Dec 2023 | $936.20 K(-85.5%) | $135.90 K(-47.3%) | $936.20 K(-7.0%) |
| Sept 2023 | - | $257.70 K(-283.7%) | $1.01 M(-31.3%) |
| June 2023 | - | -$140.30 K(-120.5%) | $1.47 M(-76.7%) |
| Mar 2023 | - | $682.90 K(+231.3%) | $6.29 M(-2.6%) |
| Dec 2022 | $6.46 M(+50.8%) | $206.10 K(-71.2%) | $6.46 M(-18.5%) |
| Sept 2022 | - | $716.50 K(-84.7%) | $7.92 M(-3.7%) |
| June 2022 | - | $4.68 M(+452.5%) | $8.22 M(+81.8%) |
| Mar 2022 | - | $848.00 K(-49.3%) | $4.52 M(+5.6%) |
| Dec 2021 | $4.28 M(+155.4%) | $1.67 M(+64.4%) | $4.28 M(+48.9%) |
| Sept 2021 | - | $1.02 M(+3.3%) | $2.87 M(+27.1%) |
| June 2021 | - | $984.70 K(+62.4%) | $2.26 M(+27.5%) |
| Mar 2021 | - | $606.30 K(+127.8%) | $1.77 M(+5.8%) |
| Dec 2020 | $1.68 M(+10.3%) | $266.10 K(-34.2%) | $1.68 M(-7.6%) |
| Sept 2020 | - | $404.20 K(-18.7%) | $1.81 M(+5.1%) |
| June 2020 | - | $497.40 K(-2.2%) | $1.72 M(+10.9%) |
| Mar 2020 | - | $508.60 K(+26.1%) | $1.55 M(+2.3%) |
| Dec 2019 | $1.52 M(-0.0%) | $403.20 K(+27.8%) | $1.52 M(+5.5%) |
| Sept 2019 | - | $315.40 K(-3.6%) | $1.44 M(+2.8%) |
| June 2019 | - | $327.30 K(-31.0%) | $1.40 M(-8.0%) |
| Mar 2019 | - | $474.20 K(+46.6%) | $1.52 M(+0.1%) |
| Dec 2018 | $1.52 M(-9.4%) | $323.40 K(+17.1%) | $1.52 M(-14.5%) |
| Sept 2018 | - | $276.20 K(-38.4%) | $1.78 M(-12.9%) |
| June 2018 | - | $448.40 K(-5.1%) | $2.04 M(+4.9%) |
| Mar 2018 | - | $472.30 K(-18.8%) | $1.95 M(+16.0%) |
| Dec 2017 | $1.68 M(+181.8%) | $582.00 K(+7.9%) | $1.68 M(+40.5%) |
| Sept 2017 | - | $539.20 K(+53.0%) | $1.19 M(+41.9%) |
| June 2017 | - | $352.50 K(+72.4%) | $841.80 K(+21.5%) |
| Mar 2017 | - | $204.50 K(+108.2%) | $693.10 K(+16.4%) |
| Dec 2016 | $595.50 K(-7.4%) | $98.20 K(-47.4%) | $595.50 K(-16.9%) |
| Sept 2016 | - | $186.60 K(-8.4%) | $716.50 K(+0.0%) |
| June 2016 | - | $203.80 K(+90.6%) | $716.20 K(+17.4%) |
| Mar 2016 | - | $106.90 K(-51.2%) | $610.20 K(-5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $643.40 K(+75.2%) | $219.20 K(+17.7%) | $643.50 K(+5.1%) |
| Sept 2015 | - | $186.30 K(+90.5%) | $612.40 K(+25.3%) |
| June 2015 | - | $97.80 K(-30.2%) | $488.90 K(+1.5%) |
| Mar 2015 | - | $140.20 K(-25.5%) | $481.70 K(+31.1%) |
| Dec 2014 | $367.30 K(+69.7%) | $188.10 K(+199.5%) | $367.40 K(+7.0%) |
| Sept 2014 | - | $62.80 K(-30.7%) | $343.50 K(+15.5%) |
| June 2014 | - | $90.60 K(+249.8%) | $297.50 K(+24.0%) |
| Mar 2014 | - | $25.90 K(-84.2%) | $240.00 K(+11.0%) |
| Dec 2013 | $216.40 K(+457.7%) | $164.20 K(+877.4%) | $216.30 K(+209.4%) |
| Sept 2013 | - | $16.80 K(-49.2%) | $69.90 K(+45.6%) |
| June 2013 | - | $33.10 K(+1404.5%) | $48.00 K(+62.2%) |
| Mar 2013 | - | $2200.00(-87.6%) | $29.60 K(-23.5%) |
| Dec 2012 | $38.80 K(-26.1%) | $17.80 K(-449.0%) | $38.70 K(+80.0%) |
| Sept 2012 | - | -$5100.00(-134.7%) | $21.50 K(-57.1%) |
| June 2012 | - | $14.70 K(+30.1%) | $50.10 K(-21.5%) |
| Mar 2012 | - | $11.30 K(+1783.3%) | $63.80 K(+21.5%) |
| Dec 2011 | $52.50 K | $600.00(-97.4%) | $52.50 K(-73.0%) |
| Sept 2011 | - | $23.50 K(-17.3%) | $194.30 K(+9.0%) |
| June 2011 | - | $28.40 K(-80.1%) | $178.30 K(+7.8%) |
| Dec 2010 | - | $142.40 K(+1798.7%) | $165.40 K(+595.0%) |
| Sept 2010 | - | $7500.00(-51.6%) | $23.80 K(+46.0%) |
| June 2010 | - | $15.50 K(+1837.5%) | $16.30 K(+13.2%) |
| Dec 2009 | - | $800.00(>+9900.0%) | $14.40 K(-34.5%) |
| Sept 2009 | - | $0.00(-100.0%) | $22.00 K(-14.7%) |
| June 2009 | - | $3700.00(-62.6%) | $25.80 K(-4.4%) |
| Mar 2009 | - | $9900.00(+17.9%) | $27.00 K(+22.2%) |
| Dec 2008 | - | $8400.00(+121.1%) | $22.10 K(+61.3%) |
| Sept 2008 | - | $3800.00(-22.4%) | $13.70 K(-38.3%) |
| June 2008 | - | $4900.00(-2.0%) | $22.20 K(+241.5%) |
| Mar 2008 | - | $5000.00(>+9900.0%) | $6500.00(-80.7%) |
| Dec 2007 | - | $0.00(-100.0%) | $33.70 K(0.0%) |
| Sept 2007 | - | $12.30 K(-213.9%) | $33.70 K(+57.5%) |
| June 2007 | - | -$10.80 K(-133.5%) | $21.40 K(-33.5%) |
| Mar 2007 | - | $32.20 K(>+9900.0%) | $32.20 K(-4700.0%) |
| Feb 2006 | - | $300.00(-130.0%) | -$700.00(-30.0%) |
| Nov 2005 | - | -$1000.00 | -$1000.00 |
FAQ
- What is Cytosorbents annual capital expenditures?
- What is the all time high annual CAPEX for Cytosorbents?
- What is Cytosorbents annual CAPEX year-on-year change?
- What is Cytosorbents quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Cytosorbents?
- What is Cytosorbents quarterly CAPEX year-on-year change?
- What is Cytosorbents TTM capital expenditures?
- What is the all time high TTM CAPEX for Cytosorbents?
- What is Cytosorbents TTM CAPEX year-on-year change?
What is Cytosorbents annual capital expenditures?
The current annual CAPEX of CTSO is $936.20 K
What is the all time high annual CAPEX for Cytosorbents?
Cytosorbents all-time high annual capital expenditures is $6.46 M
What is Cytosorbents annual CAPEX year-on-year change?
Over the past year, CTSO annual capital expenditures has changed by -$5.52 M (-85.50%)
What is Cytosorbents quarterly capital expenditures?
The current quarterly CAPEX of CTSO is $298.40 K
What is the all time high quarterly CAPEX for Cytosorbents?
Cytosorbents all-time high quarterly capital expenditures is $4.68 M
What is Cytosorbents quarterly CAPEX year-on-year change?
Over the past year, CTSO quarterly capital expenditures has changed by +$40.70 K (+15.79%)
What is Cytosorbents TTM capital expenditures?
The current TTM CAPEX of CTSO is $681.20 K
What is the all time high TTM CAPEX for Cytosorbents?
Cytosorbents all-time high TTM capital expenditures is $8.22 M
What is Cytosorbents TTM CAPEX year-on-year change?
Over the past year, CTSO TTM capital expenditures has changed by -$325.20 K (-32.31%)